Literature DB >> 17376508

Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.

Ludvik R Donner1, Luanne M Wainwright, Fan Zhang, Jaclyn A Biegel.   

Abstract

Composite rhabdoid tumors are typically adult tumors that contain a component of rhabdoid cells, which are characteristic of the aggressive childhood malignant rhabdoid tumor. Pediatric rhabdoid tumors are characterized by the inactivation of the hSNF5/INI1/SMARCB1 gene, with subsequent loss of expression of the protein. In contrast, only a single composite rhabdoid tumor has demonstrated involvement of the INI1 gene. In our study, INI1 protein expression was studied in 2 uterine carcinosarcomas with rhabdoid components (composite rhabdoid tumors). The rhabdoid component of 1 tumor showed lack of immunoreactivity for the INI1 protein and strong positivity for cyclin D1, whereas the adenocarcinomatous component of the tumor and both components of the second tumor were immunoreactive for the INI1 protein and negative for cyclin D1. Loss of one INI1 allele and a mutation in exon 7 of the remaining allele were detected in the first tumor, consistent with the immunohistochemistry results. Our results demonstrate that deletions and mutations of the INI1 gene can occur also in rare composite rhabdoid tumors of adulthood. Further studies are necessary, however, to determine the prognostic significance of this finding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376508      PMCID: PMC1963314          DOI: 10.1016/j.humpath.2006.12.003

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  32 in total

1.  Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

Authors:  N Sévenet; A Lellouch-Tubiana; D Schofield; K Hoang-Xuan; M Gessler; D Birnbaum; C Jeanpierre; A Jouvet; O Delattre
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

2.  Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.

Authors:  Michael S Isakoff; Courtney G Sansam; Pablo Tamayo; Aravind Subramanian; Julia A Evans; Christine M Fillmore; Xi Wang; Jaclyn A Biegel; Scott L Pomeroy; Jill P Mesirov; Charles W M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

3.  Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.

Authors:  D Alarcon-Vargas; Z Zhang; B Agarwal; K Challagulla; S Mani; G V Kalpana
Journal:  Oncogene       Date:  2006-02-02       Impact factor: 9.867

4.  Rhabdoid features in leiomyosarcoma of soft tissue: with special reference to aggressive behavior.

Authors:  Y Oshiro; H Shiratsuchi; Y Oda; S Toyoshima; M Tsuneyoshi
Journal:  Mod Pathol       Date:  2000-11       Impact factor: 7.842

Review 5.  Malignant mixed Müllerian tumor with rhabdoid features: a report of two cases and a review of the literature.

Authors:  D Y Baschinsky; T H Niemann; L A Eaton; W L Frankel
Journal:  Gynecol Oncol       Date:  1999-04       Impact factor: 5.482

6.  Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.

Authors:  Mary Tsikitis; Zhikai Zhang; Winfried Edelman; David Zagzag; Ganjam V Kalpana
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-12       Impact factor: 11.205

7.  INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.

Authors:  Arie Perry; Christine E Fuller; Alexander R Judkins; Louis P Dehner; Jaclyn A Biegel
Journal:  Mod Pathol       Date:  2005-07       Impact factor: 7.842

8.  Lung carcinoma with rhabdoid cells: a clinicopathological study and survival analysis of 14 cases.

Authors:  H Shimazaki; S Aida; M Sato; H Deguchi; Y Ozeki; S Tamai
Journal:  Histopathology       Date:  2001-05       Impact factor: 5.087

Review 9.  Molecular genetics of atypical teratoid/rhabdoid tumor.

Authors:  Jaclyn A Biegel
Journal:  Neurosurg Focus       Date:  2006-01-15       Impact factor: 4.047

10.  Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.

Authors:  Hironori Fujisawa; Koichi Misaki; Yasushi Takabatake; Mitsuhiro Hasegawa; Junkoh Yamashita
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

View more
  8 in total

1.  Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.

Authors:  Akihiko Yoshida; Eisuke Kobayashi; Takashi Kubo; Makoto Kodaira; Toru Motoi; Noriko Motoi; Kan Yonemori; Yuichiro Ohe; Shun-Ichi Watanabe; Akira Kawai; Takashi Kohno; Hiroshi Kishimoto; Hitoshi Ichikawa; Nobuyoshi Hiraoka
Journal:  Mod Pathol       Date:  2017-03-03       Impact factor: 7.842

2.  SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.

Authors:  Jennifer L Sauter; Rondell P Graham; Brandon T Larsen; Sarah M Jenkins; Anja C Roden; Jennifer M Boland
Journal:  Mod Pathol       Date:  2017-06-23       Impact factor: 7.842

3.  Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes.

Authors:  Abbas Agaimy; Florian Haller; Judith Frohnauer; Inga-Marie Schaefer; Philipp Ströbel; Arndt Hartmann; Robert Stoehr; Günter Klöppel
Journal:  Mod Pathol       Date:  2014-08-08       Impact factor: 7.842

4.  Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma.

Authors:  Theodoros Karantanos; Lisa Rooper; Youme Kang; Cheng Ting Lin; Pawla Wenga; Sarah Sagorsky; Josh Lauring; Hyunseok Kang
Journal:  Oncologist       Date:  2018-10-08

5.  SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.

Authors:  Abbas Agaimy; Michael Koch; Michael Lell; Sabine Semrau; Wojciech Dudek; David L Wachter; Antje Knöll; Heinrich Iro; Florian Haller; Arndt Hartmann
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

6.  Metastatic poorly differentiated chordoma: the eyes do not see what the mind does not know.

Authors:  Omar I Jaber; Maxim Al Ashhab
Journal:  Autops Case Rep       Date:  2019-09-27

7.  Right-sided rhabdoid colorectal tumors might be related to the serrated pathway.

Authors:  Massimo Pancione; Andrea Remo; Lina Sabatino; Caterina Zanella; Carolina Votino; Alessandra Fucci; Arturo Di Blasi; Giovanni Lepore; Bruno Daniele; Francesca Fenizia; Enrico Molinari; Nicola Normanno; Erminia Manfrin; Roberto Vendraminelli; Vittorio Colantuoni
Journal:  Diagn Pathol       Date:  2013-02-20       Impact factor: 2.644

8.  Sarcomatoid renal cell carcinoma with rhabdoid features.

Authors:  Nagla Ahmed Al-Saidi; Mohammed Akhtar
Journal:  Ann Saudi Med       Date:  2013 Sep-Oct       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.